Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults

Investigation of Efficacy and Tolerability of Levetiracetam for Epilepsy in Elderly

This prospective interventional study was conducted between 2023 and 2025 at the Department of Neurology of Bouali Sina Hospital. Consecutive elderly patients presenting with epilepsy were screened for eligibility. The diagnosis of epilepsy was confirmed by the treating neurologist. The patients underwent treatment with levetiracetam. Primary and secondary outcomes were investigated as was explained before.

Inclusion Criteria:

1. Age ≥60 years
2. Diagnosis of epilepsy

Exclusion Criteria:

1. Chronic kidney disease requiring dialysis
2. History of psychotic disorders or current use of anxiolytic, antidepressant, or antipsychotic medications
3. Current use of antiseizure medications for any reason